Since we have shown that CD28 itself is important in myeloma progression and survival [121,122,149], this CD28/CD86 axis may represent a possible mechanism by which cis-interactions in the myeloma cell microenvironment may facilitate survival and disease progression. This evidence concerns the gene CD86 and plasma cell myeloma.